Related Experiment Video
Updated: May 28, 2025

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Mechanisms of diabetic cardiomyopathy: Focus on inflammation
Myriam Bellemare1,2, Liane Bourcier1,2, Josep Iglesies-Grau1,2
1Department of Medicine, Montreal Heart Institute, Montreal, QC, Canada.
Insights
Type 2 diabetes (T2D) accelerates heart failure (HF) through inflammation-driven diabetic cardiomyopathy. Current therapies are limited, necessitating further research into immune pathways for novel treatments.
Area of Science:
- Cardiology
- Endocrinology
- Immunology
Background:
- Type 2 diabetes (T2D) is a significant risk factor for heart failure (HF).
- Diabetic cardiomyopathy, a direct consequence of T2D, involves myocardial alterations independent of coronary artery disease.
- Inflammation plays a critical role in the pathogenesis of diabetic cardiomyopathy.
Purpose of the Study:
- To review the pathophysiological mechanisms of diabetic cardiomyopathy, emphasizing inflammation.
- To explore diagnostic and therapeutic strategies for mitigating T2D-related myocardial damage.
Main Methods:
- Literature review focusing on T2D, inflammation, and cardiomyopathy.
- Analysis of current understanding of molecular mechanisms and therapeutic targets.
Main Results:
- Chronic low-grade inflammation is a key driver of diabetic cardiomyopathy.
- Hyperglycemia and insulin resistance in T2D activate inflammatory pathways, impairing heart function.
- Despite progress, no specific therapies targeting cardiac changes in T2D have been approved.
Conclusions:
- Elucidating inflammatory mechanisms in diabetic cardiomyopathy has advanced, but therapeutic progress is limited.
- Further investigation into immune cells and inflammatory mediators is crucial for identifying new therapeutic targets.
- Understanding molecular pathways may lead to innovative treatments and improved outcomes for T2D patients with HF.
Purpose Of Review:
Type 2 diabetes (T2D) significantly increases the risk of heart failure (HF), either through the progression of coronary artery disease (CAD) or through direct myocardial alterations, termed diabetic cardiomyopathy. This review examines key pathophysiological mechanisms underlying diabetic cardiomyopathy, focusing on the role of inflammation. It also addresses diagnostic and therapeutic approaches to mitigate myocardial damage in T2D.
Recent Findings:
Chronic low-grade inflammation is considered as a major contributor to diabetic cardiomyopathy. T2D-related factors, including hyperglycemia and insulin resistance, activate inflammatory pathways that worsen myocardial dysfunction. Despite advances in understanding these mechanisms, no therapies specifically targeting the cardiac changes in T2D have been identified.
Summary:
While significant advances have been made in elucidating the inflammatory mechanisms contributing to diabetic cardiomyopathy, therapeutic advancements remain limited, potentially due to an incomplete understanding of regulatory pathways. A comprehensive investigation into the specific roles of immune cells and inflammatory mediators in diabetic cardiomyopathy is essential for identifying novel therapeutic targets. Expanding our knowledge of these molecular mechanisms has the potential to facilitate the development of innovative therapeutic strategies, thereby improving clinical outcomes in patients with T2D.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Pathophysiology of Heart Failure
Inflammation
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Psychoneuroimmunology: Diabetes and Cancer

